By Andrea Anderson

NEW YORK (GenomeWeb News) – Researchers from the National Cancer Institute reported online in Science Translational Medicine today that they have identified gene expression and epigenetic patterns that can help predict which liver cancers are most likely to respond to treatments targeting DNA methylation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.